Dirk Soenksen, CEO, Ceresti Health

Dirk Soenksen is a strategic results-oriented healthcare executive with a demonstrated track record of building winning teams to commercialize novel technologies and services. Dirk Soenksen is co-Founder and CEO of Ceresti Health. Ceresti has built a first-of-a-kind digital health platform, and conducted the clinical studies, to prove that more knowledgeable and confident family caregivers (spouses, adult children) can improve care and outcomes for complex and underserved Medicare members. Prior to co-founding Ceresti, Mr. Soenksen was founder and CEO of venture-backed Aperio which he built into the recognized global leader in digital pathology. Aperio was acquired by Danaher/Leica Biosystems in October 2012. In 2006, Mr. Soenksen founded the Digital Pathology Association (DPA), a non-profit organization comprising major vendors and leading pathologists, with the goal of establishing best practices and increasing awareness of digital pathology. Dirk served as President of the DPA from its inception until 2012, and as a board member of the DPA through the end of 2014. He has an undergraduate degree in Chemistry from Bowdoin College, and a graduate degree in electrical engineering from the University of Pennsylvania. Dirk earned his MBA from Pepperdine University.